Endo International | ENDP - Capitale Di Prestito



Capitale Di Prestito Cambiamento Data
AbbVie USD 62.97B 12M 2025-09
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Coherus Biosciences USD 294.85M 2.33M 2025-03
Eli Lilly USD 40.87B 5.6M 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
Merck USD 39.97B 6B 2025-09
Novartis USD 24.24B 174M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Takeda JPY 4.27T 81.29B 2025-12
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Xeris Pharmaceuticals USD 219.47M 839K 2025-09
Zoetis USD 9.04B 1.97B 2025-12